News >
03/04/2007 - 22:00

C3 to sell CellSpray after review

By Staff Reporters
03/04/2007 - 22:00
Share to

Bookmark

Save articles for future reference.
Subscribe to BN Log In

PERTH-BASED burns treatment developer Clinical Cell Culture Ltd, or C3, last week announced it would close its American offices and sell its CellSpray technology after completing a strategic review of its options.

X

To read our articles you will need to either login or subscribe.